QCMC
IONS icon

Quantum Capital Management (California)’s Ionis Pharmaceuticals IONS Stock Holding History

Quantum Capital Management (California)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,660
Closed -$703K – 161
2019
Q1 		$703K Sell
8,660
-126
-1% -$8.13K 0.38% 84
2018
Q4 		$475K Sell
8,786
-525
-6% -$26.8K 0.28% 90
2018
Q3 		$480K Buy
9,311
+155
+2% +$7.28K 0.17% 124
2018
Q2 		$382K Buy
+9,156
New +$406K 0.15% 140

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantum Capital Management (California)'s IONS Position: Q2 2019 in Review

Quantum Capital Management (California) sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 8,660 shares — an estimated $703K sold.

Quantum Capital Management (California) first reported a position in IONS in Q2 2018 and held it in 4 quarters. The position peaked at $703K in Q1 2019. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

  • Quantum Capital Management (California) reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Quantum Capital Management (California) sold 8,660 Ionis Pharmaceuticals shares in Q2 2019, an estimated $703K.
  • Quantum Capital Management (California) first reported a position in Ionis Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Quantum Capital Management (California)'s Ionis Pharmaceuticals position peaked at $703K in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on Quantum Capital Management (California)'s 13F filing for Q2 2019, filed 14 Aug 2019.